Femara (letrozole)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Femara (letrozole), covering 2011-07-12 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer [Phase 1]